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Meta-analyses of randomised controlled trials (RCTs) report that polyphenol-rich diets can modulate a range of cardiometabolic bio-
markers, with increasing evidence that inter-individual factors (e.g. age, BMI, or ethnicity) contribute toward the variability in the
response to the bioactive(1,2). This systematic review and meta-analysis assessed the effect of ﬂavanols from cocoa, apple and tea
on fasting insulin and HOMA-IR and explored the role of inter-individual variability.
PubMed and Web of Science databases were searched from inception to October 2017 (PROSPERO reg. CRD42016033878). The
effect of ﬂavanols supplementation on insulin and HOMA-IR was estimated using a random effects meta-analysis model and reported
as standardised mean difference (SMD) and 95%CI. Subgroup analyses (Q tests; multivariate meta-regression) focused on baseline
BMI, gender, age, and geographical location to explore the role of inter-individual variability.
Out of 1409 studies identiﬁed, 31 RCTs were included for insulin (n = 1792) and 21 RCTs for HOMA-IR (n = 1152). Low heterogen-
eity was found between studies (insulin I2 = 0%, p = 0.98; HOMA-IR I2 = 5.9%, p = 0.38) with evidence of low publication bias.
Flavanol-rich interventions (2–26 weeks; 88 to 1344 mg ﬂavanols/day) decreased both insulin (SMD −0.25, 95% CI −0.33; −0.16)
and HOMA-IR (SMD −0.26; 95% CI −0.36, −0.16). Results were consistent across subgroups (Q tests) with lack of effect in subgroups
with BMI<25 or male subjects only; multivariate meta-regression showed that baseline BMI (overweight versus lean, coef. −1.07;
95% CI −2.03, −0.08; p = 0.03) and study location (Asia versus other sites, coef. 0.94; 95% CI 0.03,1.84; p = 0.04) impacted on the effect
on HOMA-IR signiﬁcantly. There was no impact of age, gender, baseline BMI or geographical location on the effect on insulin.
Flavanols from tea, apple and cocoa were effective in modulating insulin and HOMA-IR. Inter-individual variability in the
response was limited in contrast to previous studies(1,2). This could be partly explained by the small number of trials reporting
data for speciﬁc subgroups, and the broad range of doses and duration tested among the studies.
1. Pinto P & Santos C. Eur J Nutr. 2017;56(4):1393–1408.
2. González-Sarrías A, Combet E, Pinto P et al. Nutrients. 2017;9(7):746.
Factor Subgroup Insulin (95% CI) Q value (n, N) HOMA-IR (95% CI) Q value (n, N)
Age <50 years −0.21 (−0.36, −0.05) Q bet 0.276
p = 0.6
(15, 662) −0.34 (−0.54, −0.14) Q bet 0.62
p = 0.43
(13, 522)
>50 years −0.26 (−0.36, −0.15) (24, 1373) −0.22 (−0.35, −0.10) (14, 630)
All −0.24 (−0.33, −0.15) −0.25 (−0.36, −0.15)
Gender Male −0.12 (−0.40, 0.15) Q bet 1.46,
p = 0.48
(3, 14) N/A
Female −0.21 (−0.37, −0.04) (9, 475) −0.09 (−0.28, 0.09) N/A (7, 372)
All −0.25 (−0.33, −0.16)
Baseline BMI (kg/M2) <25 −0.2 (−0.44, 0.03) Q bet 1.67
p = 0.4
(4, 156) −0.10 (−0.42, 0.22) Q bet 2.4
p = 0.29
(2, 98)
25–30 −0.31 (−0.34, −0.16) (13, 898) −0.32 (−0.46, −0.19) (12, 653)
>30 −0.19 (−0.33, −0.05) (12, 696) −0.23 (−0.43, −0.04) (12, 401)
All −0.25 (−0.33, −0.16) −0.27 (−0.38, −0.17)
Geographical location Asia −0.19 (−0.33, −0.04) Q bet 1.01
p = 0.79
(13, 748) −0.20 (−0.34, −0.05) Q bet 2.27
p = 0.51
(8, 496)
USA −0.27 (−0.52, −0.02) (5, 213) −0.29 (−0.63, 0.06) (6, 106)
Europe −0.29 (−0.42, −0.16) (21, 731) −0.36 (−0.53, −0.19) (10, 434)
Other −0.33 (−0.69, 0.05) (3, 100) −0.29 (−0.74, 0.17) (3, 100)
All −0.25 (−0.33, −0.16) −0.27 (−0.37, −0.17)
Values are showed in SMD (95%CI). n, number of trials; N, number of participants.
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